For instance, buparlisib suppresses the expression of hexokinase 2 (HK2) and pyruvate kinase M2 (PKM2) [48, 49], critical glycolytic enzymes, thereby hindering glycolytic flux and energy production in cancer cells. The gene discussed is HK2; the disease is cancer.